Viking Therapeutics Inc (VKTX) Insider Trading
- $1,600,028.20
- $116,800,841.46
- March 10, 2026
- Brian Lian
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 10, 2026 | Insider | 4,475 | $33.50 | Buy | $149,912.50 | |
| July 3, 2025 | CFO | 4,266 | $27.76 | Sell | $118,424.16 | |
| July 3, 2025 | COO | 4,266 | $27.77 | Sell | $118,466.82 | |
| July 3, 2025 | CEO | 26,889 | $27.80 | Sell | $747,514.20 | |
| March 31, 2025 | Director | 1,240 | $24.15 | Buy | $29,946.00 | |
| Jan. 6, 2025 | COO | 54,215 | $42.75 | Sell | $2,317,691.25 | |
| Jan. 6, 2025 | CFO | 50,309 | $42.75 | Sell | $2,150,709.75 | |
| Jan. 6, 2025 | CEO | 194,490 | $42.75 | Sell | $8,314,447.50 | |
| Nov. 8, 2024 | Director | 2,000 | $68.67 | Sell | $137,340.00 | |
| Oct. 28, 2024 | CFO | 131,687 | $76.61 | Sell | $10,088,541.07 | |
| Oct. 25, 2024 | Director | 11,000 | $80.89 | Sell | $889,790.00 | |
| Sept. 20, 2024 | CEO | 216,130 | $70.83 | Sell | $15,308,487.90 | |
| Sept. 20, 2024 | Director | 10,300 | $69.50 | Sell | $715,850.00 | |
| Aug. 21, 2024 | Director | 5,700 | $69.72 | Sell | $397,404.00 | |
| Aug. 21, 2024 | CEO | 1,000 | $69.90 | Sell | $69,900.00 | |
| Aug. 19, 2024 | Director | 16,000 | $62.22 | Sell | $995,520.00 | |
| Aug. 19, 2024 | CEO | 112,870 | $65.80 | Sell | $7,426,846.00 | |
| Aug. 14, 2024 | Director | 20,786 | $57.53 | Sell | $1,195,818.58 | |
| July 30, 2024 | COO | 18,026 | $57.13 | Sell | $1,029,825.38 | |
| July 30, 2024 | Insider | 16,136 | $57.15 | Buy | $922,172.40 | |
| July 30, 2024 | CEO | 115,859 | $57.58 | Sell | $6,671,161.22 | |
| May 3, 2024 | CFO | 66,756 | $74.69 | Sell | $4,986,005.64 | |
| May 1, 2024 | COO | 281,425 | $78.66 | Sell | $22,136,890.50 | |
| Feb. 8, 2024 | CEO | 269,079 | $26.87 | Sell | $7,230,152.73 | |
| Feb. 8, 2024 | Director | 25,000 | $28.05 | Sell | $701,250.00 | |
| Jan. 30, 2024 | CEO | 35,000 | $23.95 | Sell | $838,250.00 | |
| Jan. 19, 2024 | Director | 30,000 | $23.05 | Sell | $691,500.00 | |
| Jan. 4, 2024 | CFO | 15,000 | $17.90 | Sell | $268,500.00 | |
| May 16, 2023 | Director | 40,000 | $25.00 | Sell | $1,000,000.00 | |
| May 1, 2023 | CEO | 45,000 | $22.45 | Sell | $1,010,250.00 | |
| April 24, 2023 | Director | 16,000 | $22.00 | Sell | $352,000.00 | |
| April 19, 2023 | CEO | 35,000 | $21.45 | Sell | $750,750.00 | |
| April 17, 2023 | Director | 20,786 | $20.00 | Sell | $415,720.00 | |
| April 17, 2023 | CEO | 155,000 | $20.45 | Sell | $3,169,750.00 | |
| April 17, 2023 | COO | 12,500 | $20.00 | Sell | $250,000.00 | |
| April 17, 2023 | CFO | 7,500 | $20.00 | Sell | $150,000.00 | |
| April 13, 2023 | CEO | 79,336 | $18.45 | Sell | $1,463,749.20 | |
| April 11, 2023 | CFO | 56,295 | $18.00 | Sell | $1,013,310.00 | |
| April 3, 2023 | CFO | 30,911 | $18.00 | Sell | $556,398.00 | |
| April 3, 2023 | CEO | 22,000 | $17.85 | Sell | $392,700.00 | |
| March 31, 2023 | CEO | 67,970 | $17.45 | Sell | $1,186,076.50 | |
| March 30, 2023 | CFO | 131,029 | $17.00 | Sell | $2,227,493.00 | |
| March 29, 2023 | COO | 41,242 | $16.00 | Sell | $659,872.00 | |
| June 10, 2021 | Director | 20,000 | $5.69 | Buy | $113,800.00 | |
| Aug. 26, 2020 | Major Shareholder | 164,488 | $8.07 | Sell | $1,327,418.16 | |
| June 30, 2020 | Director | 13,000 | $7.35 | Sell | $95,550.00 | |
| Sept. 25, 2018 | Major Shareholder | 262,881 | $19.15 | Sell | $5,034,171.15 | |
| May 31, 2018 | Director | 9,500 | $9.82 | Buy | $93,290.00 | |
| May 31, 2018 | VP | 21,551 | $9.25 | Sell | $199,346.75 | |
| May 29, 2018 | Director | 47,965 | $5.22 | Buy | $250,377.30 |
Insiders are both buying and selling Viking Therapeutics Inc stock.
The insider traders at Viking Therapeutics Inc are: Brian Lian, Greg Zante, Marianna Mancini, J Matthew Singleton, Lawson Macartney, Matthew W Foehr, Sarah Kathryn Rouan, Ligand Pharmaceuticals Inc, Michael Morneau, Neil William Aubuchon, Zante Greg, and Charles A Rowland Jr
The most active insider trader at Viking Therapeutics Inc is Brian Lian with 14 trades.
Brian Lian has sold the most Viking Therapeutics Inc stock with a total value of $55,327,549.45.
Zante Greg has bought the most Viking Therapeutics Inc stock with a total value of $1,844,344.80.
The most recent insider trade for Viking Therapeutics Inc was on March 10, 2026.
The single biggest insider buy for Viking Therapeutics Inc was from Zante Greg with a total value of $922,172.40 on July 30, 2024.
The single biggest insider sell for Viking Therapeutics Inc was from Marianna Mancini with a total value of $22,136,890.50 on May 1, 2024.
